GE HealthCare Technologies Inc. (GEHC)

US — Healthcare Sector
Peers: HUM  IQV  CAH  INSM  ALC  ONC  RMD  A  MTD  PHG 

Automate Your Wheel Strategy on GEHC

With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol GEHC
  • Rev/Share 44.3969
  • Book/Share 22.4123
  • PB 3.353
  • Debt/Equity 0.2006
  • CurrentRatio 0.9992
  • ROIC 0.0936

 

  • MktCap 33562154301.0
  • FreeCF/Share 1.0154
  • PFCF 72.4885
  • PE 15.1204
  • Debt/Assets 0.0555
  • DivYield 0.0019
  • ROE 0.2374

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 3
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation GEHC Barclays -- Equal Weight -- $86 Oct. 13, 2025
Downgrade GEHC Citigroup Buy Neutral -- $83 Oct. 7, 2025
Upgrade GEHC UBS Sell Neutral -- $73 May 5, 2025
Upgrade GEHC Goldman Neutral Buy $85 $100 March 11, 2025
Upgrade GEHC Jefferies Hold Buy $95 $103 Jan. 8, 2025
Downgrade GEHC UBS Neutral Sell $84 $74 Sept. 26, 2024
Upgrade GEHC BTIG Research Neutral Buy -- $100 Sept. 18, 2024
Initiation GEHC JP Morgan -- Neutral -- $90 Sept. 9, 2024

News

Why GE HealthCare Technologies (GEHC) is a Top Momentum Stock for the Long-Term
GEHC
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why GE HealthCare Technologies (GEHC) is a Top Momentum Stock for the Long-Term
GEHC vs. ESLOY: Which Stock Is the Better Value Option?
ESLOY, GEHC
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news GEHC vs. ESLOY: Which Stock Is the Better Value Option?
GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call Transcript
GEHC
Published: October 29, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. ( GEHC ) Q3 2025 Earnings Call October 29, 2025 8:30 AM EDT Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President, CEO & Director James Saccaro - VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Travis Steed - BofA Securities, Research Division Joanne Wuensch - Citigroup Inc., Research Division David Roman - Goldman Sachs Group, Inc., Research Division Patrick Wood - Morgan Stanley, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Robert Marcus …

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call Transcript
GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates
GEHC
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.14 per share a year ago.

Read More
image for news GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates
GE HealthCare boosts 2025 profit view after strong US demand helps third quarter
GEHC
Published: October 29, 2025 by: Reuters
Sentiment: Positive

GE HealthCare Technologies raised its annual adjusted profit forecast and beat estimates for third-quarter results on Wednesday, powered by strong demand for its medical devices in the United States and the Europe, Middle East, and Africa region.

Read More
image for news GE HealthCare boosts 2025 profit view after strong US demand helps third quarter
GE HealthCare Tech Profit Slides as Tariffs Drag
GEHC
Published: October 29, 2025 by: WSJ
Sentiment: Negative

GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs.

Read More
image for news GE HealthCare Tech Profit Slides as Tariffs Drag
GE HealthCare reports third quarter 2025 financial results
GEHC
Published: October 29, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment. Revenue performance was driven by Imaging, Advanced Visualization Solutions, and Pharmaceutical Diagnostics, and was ah.

Read More
image for news GE HealthCare reports third quarter 2025 financial results
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
GEHC
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Neutral

GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.

Read More
image for news Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GEHC
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.

Read More
image for news GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GEHC
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.

Read More
image for news GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.

Read More
image for news GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GEHC
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.

Read More
image for news GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GEHC or A: Which Is the Better Value Stock Right Now?
A, GEHC
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news GEHC or A: Which Is the Better Value Stock Right Now?
GE HealthCare (GEHC) Upgraded to Strong Buy: What Does It Mean for the Stock?
GEHC
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Read More
image for news GE HealthCare (GEHC) Upgraded to Strong Buy: What Does It Mean for the Stock?
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
GEHC
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare debuts AI-powered Voluson Performance ultrasound systems, enhancing women's health imaging with faster, smarter diagnostics.

Read More
image for news GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
GEHC
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.

Read More
image for news GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
GE HealthCare Technologies Inc. (GEHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
GEHC
Published: September 09, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Peter Arduini - President, CEO & Director Carolynne Borders - Chief Investor Relations Officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Research Hello, everyone. Thank you so much for joining.

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
GEHC
Published: September 08, 2025 by: Business Wire
Sentiment: Neutral

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare and CDL Nuclear Technologies Group enter agreement to distribute Flyrcado to CDL customer sites around the U.S.

Read More
image for news GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
GEHC
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare's FDA-cleared Revolution Vibe CT promises faster, AI-driven cardiac imaging with improved clarity, boosting efficiency and patient comfort.

Read More
image for news GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
GE HealthCare Technologies Inc. (GEHC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
GEHC
Published: September 04, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:45 AM EDT Company Participants James Saccaro - VP & CFO Carolynne Borders - Chief Investor Relations Officer Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo.

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
GEHC or A: Which Is the Better Value Stock Right Now?
A, GEHC
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Agilent Technologies (A). But which of these two stocks is more attractive to value investors?

Read More
image for news GEHC or A: Which Is the Better Value Stock Right Now?
GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System
GEHC
Published: September 01, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare's Vivid Pioneer, cleared by CE Mark and FDA, brings AI-powered speed, precision and efficiency to cardiac imaging.

Read More
image for news GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
BSX, GEHC, JNJ, TEM
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive

AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.

Read More
image for news 4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
GEHC Positioned for Growth With AI, Global Expansion and Margins
GEHC
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand.

Read More
image for news GEHC Positioned for Growth With AI, Global Expansion and Margins
GEHC or A: Which Is the Better Value Stock Right Now?
A, GEHC
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two stocks offers value investors a better bang for their buck right now?

Read More
image for news GEHC or A: Which Is the Better Value Stock Right Now?
What Makes GE HealthCare (GEHC) a New Strong Buy Stock
GEHC
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read More
image for news What Makes GE HealthCare (GEHC) a New Strong Buy Stock
GEHC vs. BSX: Which Stock Is the Better Value Option?
BSX, GEHC
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?

Read More
image for news GEHC vs. BSX: Which Stock Is the Better Value Option?
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.

Read More
image for news GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
GEHC
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP & CFO Peter J.

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
GEHC
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More
image for news Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics

About GE HealthCare Technologies Inc. (GEHC)

  • IPO Date 2022-12-15
  • Website https://www.gehealthcare.com
  • Industry Medical - Healthcare Information Services
  • CEO Peter J. Arduini
  • Employees 53000

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.